What to Know about the Medicare Open Enrollment Period and Medicare Coverage Options

Published: Sep 26, 2024

This document was updated on Oct. 4, 2024 to clarify that a new Special Enrollment Period (effective Jan. 1, 2025), which allows individuals who are dually-eligible for Medicare and full Medicaid benefits to make certain changes to their Medicare coverage outside of open enrollment, applies on a monthly basis, not quarterly as was previously stated.

Medicare is the federal health insurance program for 67 million people ages 65 and over and younger adults with long-term disabilities. The program helps to pay for many medical care services, including hospitalizations, physician visits, and prescription drugs, along with post-acute care, skilled nursing facility care, home health care, hospice care, and preventive services.

People with Medicare may choose to receive their Medicare benefits through traditional Medicare or through a Medicare Advantage plan, such as an HMO or PPO, administered by a private health insurer. People who choose traditional Medicare may sign up for a separate Medicare Part D prescription drug plan for coverage of outpatient prescription drugs and may also consider purchasing a supplemental insurance policy to help with out-of-pockets costs if they do not have additional coverage from a former employer, union, or Medicaid. People who opt for Medicare Advantage can choose among dozens of Medicare Advantage plans, which include all services covered under Medicare Parts A and B, and often include Part D prescription drug coverage as well.

Each year, Medicare beneficiaries have an opportunity to make changes to how they receive their Medicare coverage during the nearly 8-week annual open enrollment period. This brief answers key questions about the Medicare open enrollment period and Medicare coverage options.

1. When is the annual Medicare open enrollment period?

The annual Medicare open enrollment period runs from October 15th to December 7th each year (Figure 1). During this time, people with Medicare can review features of Medicare plans offered in their area and make changes to their Medicare coverage, which go into effect on January 1st of the following year. These changes include switching from traditional Medicare to a Medicare Advantage plan (or vice versa), switching between Medicare Advantage plans, and electing or switching between Medicare Part D prescription drug plans.

Figure 1 is a calendar representation of its title, with the select dates highlighted blue. Title: "Medicare’s Open Enrollment Period Runs from October 15 to December 7 Each Year"

2. What changes can Medicare beneficiaries make during the annual open enrollment period?

People in traditional Medicare can use the Medicare open enrollment period to enroll in a Medicare Part D prescription drug plan or switch between Part D plans. Traditional Medicare beneficiaries who did not sign up for a Part D plan during their initial enrollment period can enroll in a Part D plan during the annual open enrollment period, though they may be subject to a late enrollment penalty if they did not have comparable prescription drug coverage from another plan before signing up for Part D. Traditional Medicare beneficiaries with Medicare Parts A and B can also use this time to switch from traditional Medicare into a Medicare Advantage plan, with or without Part D coverage.

People who are enrolled in a Medicare Advantage plan can use the Medicare open enrollment period to choose a different Medicare Advantage plan or switch to traditional Medicare. Medicare Advantage enrollees who switch to traditional Medicare can enroll in a Part D plan if they want outpatient prescription drug coverage, which is not covered under Medicare Parts A and B. They may also consider purchasing a Medicare supplemental insurance policy (Medigap) if the option is available to them (see question 4 for details about Medigap and potential limits on enrollment).

Medicare beneficiaries are encouraged to review their current source of Medicare coverage during the annual open enrollment period and compare other options that are available where they live. Because an individual’s medical needs can change over the course of the year, and from one year to the next, this may influence their priorities when choosing how they want to get their Medicare benefits. Medicare Advantage and Medicare prescription drug plans typically change from one year to the next and may vary in many ways that could have implications for a person’s access to providers and costs. Despite this, a KFF analysis of a nationally representative survey of people with Medicare found that nearly 7 in 10 (69%) did not compare their Medicare coverage options during a recent open enrollment period (Figure 2).

The Share of Medicare Beneficiaries Who Did Not Compare Medicare Coverage Options During Open Enrollment Was Higher Among Certain Subgroups

3. Are there other opportunities for Medicare beneficiaries to make coverage changes outside of the open enrollment period?

Some Medicare beneficiaries can make certain changes to their coverage at other times of the year. For example, beneficiaries who experience disruptions to existing coverage (such as a cross-county move or a loss of employer- or union-sponsored coverage) or changes in eligibility for Medicaid or other programs, may qualify for a Special Enrollment Period at any time of year. People who are enrolled in both Medicare and Medicaid (i.e., dual-eligible individuals) or who qualify for the Medicare Part D Extra Help program, can currently change their Medicare Advantage or Medicare Part D coverage once per quarter. People living in nursing homes and certain other facilities may change their Medicare Advantage or Medicare Part D coverage once per month.

Beginning on January 1, 2025, new rules go into effect related to the type and frequency of changes dual-eligible individuals and those who qualify for Extra Help can make to their Medicare coverage. Beneficiaries in this group will be allowed to disenroll from a Medicare Advantage plan into traditional Medicare on a monthly basis and may choose to enroll in a stand-alone Part D drug plan at that time. People who receive full Medicaid benefits will only be allowed to switch between Medicare Advantage plans on a monthly basis if switching to a Fully Integrated Dually Eligible Special Needs Plan (FIDE SNP), a Highly Integrated Dually Eligible Special Needs Plan (HIDE SNP), or a coordination-only D-SNP that is an Applicable Integrated Plan (AIP) that is aligned with their Medicaid managed care enrollment. People who receive partial Medicaid benefits, or who qualify for the Extra Help program but do not receive Medicaid benefits, will no longer be allowed to switch between Medicare Advantage plans outside of open enrollment.

Medicare Advantage enrollees who wish to change plans or switch to traditional Medicare may do so between January 1st through March 31st each year, during the Medicare Advantage Open Enrollment Period. (This is in addition to the open enrollment period that runs from October 15th to December 7th.) Additionally, those who have a Medicare Advantage or Medicare Part D plan with a 5-star quality rating available in their area may switch into a 5-star plan between December 8th and November 30th of the following year.

The annual open enrollment period and other opportunities to switch coverage are distinct from the initial enrollment period for people who are newly enrolling in Medicare, which begins three months before a person’s 65th birthday and ends three months after it. For more information on initial enrollment, see the Medicare Open Enrollment FAQ.

4. How does supplemental coverage, like Medigap and employer-sponsored retiree health benefits, factor into Medicare coverage decisions?

Many Medicare beneficiaries have some form of additional coverage, such as a Medicare Supplemental Insurance policy (Medigap) or coverage offered by an employer or a union, that helps with Medicare’s cost-sharing requirements. Enrollment in these plans and programs is not tied to the open enrollment period, though beneficiaries may wish to take them into account when considering their options for Medicare coverage.

Medigap. People in traditional Medicare with both Part A and Part B can apply for a Medigap policy at any time of the year. Medigap policies are designed to help beneficiaries in traditional Medicare with Medicare’s deductibles and cost-sharing requirements and have standard benefits to allow for apples-to-apples comparisons across insurers. Traditional Medicare beneficiaries with a Medigap plan that covers most deductible and cost-sharing requirements may have lower out-of-pocket spending for Medicare-covered services than people with other coverage, including a Medicare Advantage plan. Medigap policies are designed to wrap around traditional Medicare, and do not work with Medicare Advantage. People enrolled in Medicare Advantage do not need (and can’t buy) a Medigap policy.

While Medigap insurers are required to issue policies to people age 65 or over, without regard to health status or diagnosed medical conditions when they first enroll in Medicare, those with pre-existing conditions may be denied a Medigap policy or face higher premiums in most states if they apply for Medigap coverage after their first six months of enrollment in Part B. People who disenroll from Medicare Advantage within 12 months of first enrolling in Medicare Advantage have a right to purchase a Medigap policy without regard to medical history, but after 12 months, they are not guaranteed Medigap coverage and may be denied a policy due to a pre-existing condition or face higher Medigap premiums if they are offered a policy.

Medigap guaranteed issue rights are different for people under age 65 who qualify for Medicare due to long-term disability. Federal law does not require Medigap insurers to sell a policy to people with Medicare under age 65, although several states do require insurers to offer at least one kind of Medigap policy to people under 65. Premiums for Medigap policies sold to people under age 65 are typically higher than policies sold to those age 65 or older. People under age 65 with disabilities who are already enrolled in Medicare will qualify for the 6-month Medigap open enrollment period when they turn 65 and become age eligible for Medicare. At this point, they can buy any Medigap policy they want without facing higher premiums or denials of coverage based on their existing medical conditions.

Employer-sponsored coverage. While employer-sponsored retiree health benefits are on the decline, more than 14.5 million people with Medicare have retiree health coverage (distinct from people with Medicare Part A only who continue to work and have health insurance through their current employer or a spouse’s current employer). Retiree health benefits may be designed to supplement either traditional Medicare or Medicare Advantage. Some employers that offer benefits to retirees on Medicare offer retiree health benefits exclusively through a Medicare Advantage plan. Beneficiaries with retiree health coverage offered exclusively through a Medicare Advantage plan may lose retiree health benefits if they choose to switch to traditional Medicare during the annual open enrollment period. Similarly, employers may only offer a retiree health benefit that supplements traditional Medicare. If a person with such coverage switches from traditional Medicare to Medicare Advantage during an open enrollment period, they may lose their retiree health benefits. In fact, if a Medicare beneficiary drops their employer or union-sponsored retiree health benefits for any reason, they may not be able to get them back.

5. How does additional support for low-income people factor into Medicare coverage decisions?

Low-income Medicare beneficiaries who meet their states’ Medicaid eligibility criteria qualify for additional coverage of services not covered under Medicare, such as long-term services and supports. Additionally, Medicare beneficiaries with modest incomes may qualify for assistance with Medicare premiums and out-of-pocket costs from the Medicare Savings Programs (MSP) and Part D Low-Income Subsidy (LIS) if their income and assets are below certain amounts. Medicare beneficiaries who are eligible for Medicaid, the Medicare Savings Programs, or Medicare Part D Low-Income Subsidies, but not yet enrolled in these programs, can enroll at any time of the year. This additional coverage and assistance may factor into how people choose to receive their Medicare benefits.

Medicaid. For people who qualify for full Medicaid benefits, the choice of Medicare coverage can impact how they receive those benefits and the degree to which those benefits are coordinated with Medicare. In general, Medicaid wraps around Medicare coverage, with Medicare as the primary payer and Medicaid paying for costs and services not covered by Medicare. People dually eligible for Medicare and Medicaid can enroll in a Medicare Advantage plan designed for this population, such as a dual-eligible special needs plan (SNP), and depending on the state and the plan, experience a higher level of coordination of their benefits. People who qualify for full Medicaid benefits can currently switch their Medicare coverage outside of the open enrollment period, up to once per quarter. Beginning on January 1, 2025, new rules go into effect related to the type and frequency of changes dual-eligible individuals can make to their Medicare coverage (see Q3 for further details).

Medicare Savings Programs. State Medicaid programs pay Medicare premiums and, in many cases, cost sharing for Medicare beneficiaries who have income and assets below certain amounts (though some states have lifted their income and/or asset thresholds above the federal limits). Specifically, states cover the Medicare Part B premium for people who qualify and may also provide assistance with Medicare deductibles and other cost-sharing requirements. People who receive MSP assistance and are enrolled in a Medicare Advantage plan may still have cost sharing associated with non-Medicare covered services offered by the plan. People who qualify for MSP can also switch their coverage outside of the open enrollment period, up to once per quarter.

Part D Low-Income Subsidy. People who qualify for the Part D Low-Income Subsidy (LIS) receive varying levels of assistance toward their Part D prescription drug coverage premiums and cost sharing, depending on their income and asset levels. Dual-eligible individuals and people enrolled in the Medicare Savings Programs automatically qualify for full LIS benefits, and Medicare automatically enrolls them into a stand-alone Part D drug plan in their area with a premium at or below the regional average (the Low-Income Subsidy benchmark) if they do not choose a plan on their own. Other beneficiaries are subject to both an income and asset test and need to apply for the LIS through either the Social Security Administration or Medicaid. People who receive LIS assistance can select any Part D plan offered in their area, but if they enroll in a plan that is not a so-called “benchmark plan” (that is, plans available without a premium to enrollees receiving full LIS), or their current plan loses benchmark status, they may be required to pay some portion of their plan’s monthly premium, which would diminish the value of the subsidy.

6. How do the features of traditional Medicare compare to those of Medicare Advantage?

Traditional Medicare and Medicare Advantage both provide coverage of all services included in Medicare Part A and Part B, but certain features, such as out-of-pocket costs, provider networks, and access to extra benefits vary between these two types of Medicare coverage. When deciding between traditional Medicare and Medicare Advantage, Medicare beneficiaries may want to consider a variety of factors, such as their own health and financial circumstances, preferences for how they get their medical care, which providers they see, and their prescription drug needs. These decisions may involve careful consideration of premiums, deductibles, cost sharing and out-of-pocket spending; extra benefits offered by Medicare Advantage plans; how the choice of coverage option may affect access to certain physicians, specialists, hospitals and pharmacies; rules related to prior authorization and referral requirements; and variations in coverage and costs for prescription drugs.

People may prefer traditional Medicare if they want the broadest possible access to doctors, hospitals and other health care providers. Traditional Medicare beneficiaries may see any provider that accepts Medicare and is accepting new patients. People with traditional Medicare are not required to obtain a referral for specialists or mental health providers. Additionally, prior authorization is rarely required in traditional Medicare and only applies to a limited set of services. With traditional Medicare, people have the ability to choose among stand-alone prescription drug plans offered in their area, which tend to vary widely in terms of which drugs are covered and at what cost.

People may prefer Medicare Advantage if they want extra benefits, such as coverage of some dental and vision services, and reduced cost sharing offered by these plans, often for no additional premium (other than the Part B premium). Additionally, Medicare Advantage plans are required to include a cap on out-of-pocket spending, providing some protection from catastrophic medical expenses. Medicare Advantage plans also offer the benefit of one-stop shopping (i.e., people who enroll have coverage under one plan and do not need to sign up for a separate Part D prescription drug plan or a Medigap policy to supplement traditional Medicare).

7. How do Medicare Advantage plans vary?

The average Medicare beneficiary can choose from 43 Medicare Advantage plans (Figure 3) offered by 8 insurance companies in 2024. These plans vary across many dimensions, including premiums and out-of-pocket spending, provider networks, extra benefits, prior authorization and referral requirements, and prescription drug coverage. As a result, enrollees face different out-of-pocket costs, access to providers and pharmacies, and coverage of non-Medicare benefits (such as dental, vision and hearing) based on the Medicare Advantage plan they choose.

The Average Medicare Beneficiary Can Choose from 43 Medicare Advantage Plans in 2024

Premiums and out-of-pocket spending. Medicare Advantage enrollees may be charged a separate monthly premium (in addition to the Part B premium). In 2024, the average enrollment-weighted premium for Medicare Advantage plans was $14 per month, though three quarters (75%) of enrollees were in plans that charged no additional premium (apart from the Part B premium).

Medicare Advantage plans are generally prohibited from charging more than traditional Medicare, but vary in the deductibles, co-pays and co-insurance they require. For example, plans typically charge a daily co-pay for hospital stays, which vary both in the amount and the number of days for which they apply.

Medicare Advantage plans are required to include a cap on out-of-pocket expenses. In 2024, this cap may not exceed $8,850 for in-network services or $13,300 for all covered services. Most plans have an out-of-pocket limit below this cap, averaging $4,882 for in-network services and $8,707 for in-network and out-of-network services combined. Out-of-pocket limits only apply to services covered under Medicare Parts A and B.

Provider networks. Medicare Advantage plans are permitted to limit their provider networks, the size of which can vary considerably for both physicians and hospitals, depending on the plan and the county where it is offered. Medicare Advantage plans that include prescription drug coverage may also establish pharmacy networks or designate preferred pharmacies, where enrollees will have lower out-of-pocket costs. If a Medicare Advantage plan provides coverage of out-of-network providers, it may require higher cost sharing from enrollees for these services.

Extra benefits. Medicare Advantage plans may choose to offer extra benefits not covered by traditional Medicare, such as some coverage of dental, vision, and hearing services. Virtually all Medicare Advantage enrollees are in a plan that offers extra benefits, including some coverage of eye exams and/or eyeglasses (more than 99%), dental care (98%), hearing exams and/or aids (96%), and a fitness benefit (95%). Additionally, a majority of Medicare Advantage enrollees are in plans that provide an allowance for over-the-counter items (88%) and meals following a hospital stay (74%). While extra benefits are common, the scope of coverage varies widely from plan to plan. For example, in 2021, more than half (59%) of Medicare Advantage enrollees were in a plan with a maximum dental benefit of $1,000 or less, while nearly one-third (30%) were in a plan with a limit between $2,000 and $5,000.

Prior authorization and referral requirements. Medicare Advantage plans may require enrollees to receive prior authorization before a service will be covered. In 2022, more than 46 million prior authorization requests were submitted to insurers on behalf of Medicare Advantage enrollees, and in 2024, virtually all Medicare Advantage enrollees were in plans that required prior authorization for some services, such as inpatient hospital stays, diagnostic tests and procedures, or stays in a skilled nursing facility. Prior authorization may also be required for some services included in a plan’s extra benefits, such as hearing and eye exams or comprehensive dental services. In addition, Medicare Advantage plans may require enrollees to obtain a referral from a primary care provider in order to see a specialist or mental health provider.

Prescription drug coverage. Medicare Advantage enrollees who want prescription drug coverage must choose a plan that offers this coverage, as they are not permitted to enroll in a stand-alone prescription drug plan while enrolled in Medicare Advantage. Medicare Advantage plans that include prescription drug coverage may also charge a drug deductible. Drug coverage in Medicare Advantage plans varies along the same dimensions as drug coverage in stand-alone Part D plans (described below).

8. How do Part D plans vary?

The average Medicare beneficiary has 21 stand-alone Part D plans to choose from in 2024 (Figure 4) (in addition to a large number of Medicare Advantage drug plans, if they want to consider Medicare Advantage for all of their Medicare-covered benefits). For traditional Medicare beneficiaries who want to add Part D coverage, stand-alone Part D plans vary in terms of premiums, deductibles and cost sharing, the drugs that are covered and any utilization management restrictions that apply, and pharmacy networks. These differences can affect enrollees’ access to prescription drugs and out-of-pocket costs.

The Average Medicare Beneficiary Has a Choice of 21 Stand-Alone Medicare Part D Drug Plans in 2024

Premiums. People in traditional Medicare who are enrolled in a separate stand-alone Part D plan generally pay a monthly Part D premium unless they qualify for full benefits through the Part D Low-Income Subsidy (LIS) program and are enrolled in a premium-free (benchmark) plan. In 2024, the average enrollment-weighted premium for stand-alone Part D plans was $43 per month. Changes to the Part D benefit in the Inflation Reduction Act, such as the new $2,000 cap on out-of-pocket drug spending for Part D enrollees, will mean lower out-of-pocket costs for many Medicare beneficiaries but higher costs for Part D plans overall, leading to concerns about possible premium increases for 2025 (see Q9 for further discussion of the Inflation Reduction Act).

Deductibles and cost sharing. Deductibles and cost-sharing requirements for prescription drug coverage are variable. Plans generally impose a tier structure to define cost sharing requirements and cost sharing amounts charged. Plans typically charge lower cost-sharing amounts for generic drugs and preferred brands and higher amounts for non-preferred and specialty drugs, and charge a mix of flat dollar copayments and coinsurance (based on a percentage of a drug’s list price) for covered drugs.

Drugs covered and utilization management restrictions. Part D plans include a list of drugs they cover (also referred to as a plan’s formulary). In addition, plans may also impose utilization management restrictions on covered prescription drugs, including prior authorization, quantity limits, and step therapy, which can affect beneficiaries’ access to medications. In 2024, around 30% of covered drugs are subject to prior authorization.

Pharmacy networks. Part D prescription drug plans may establish pharmacy networks or designate preferred pharmacies, where enrollees will have lower out-of-pocket costs.

9. Do the Medicare prescription drug changes in the Inflation Reduction Act differ across Medicare coverage options?

No. The prescription drug provisions in the Inflation Reduction Act of 2022 that aim to lower out-of-pocket costs apply to all Part D plans, including both stand-alone Part D plans and Medicare Advantage Prescription Drug plans. Regardless of whether beneficiaries get their drug coverage from a stand-alone Part D plan or a Medicare Advantage drug plan, they will benefit from these changes.

As of 2023, cost sharing for insulin is now capped at $35 per month per prescription. All Medicare Part D plans, both stand-alone drug plans and Medicare Advantage drug plans, will be required to charge no more than $35 for whichever insulin products they cover, although plans will not be required to cover all insulin products. Beneficiaries who use a specific insulin product should verify coverage of their product before enrolling in a specific plan.

Also as of 2023, adult vaccines covered under Medicare Part D that have been recommended by the Advisory Committee on Immunization Practices (ACIP) must now be covered at no cost to enrollees. This change does not impact the small number of vaccines covered under Medicare Part B (such as the flu, pneumonia, and COVID-19 vaccines), many of which were already covered free of cost. Finally, drug companies are now required to pay rebates to the Medicare program if the cost of drugs used by Medicare beneficiaries rises faster than the rate of inflation each year, similar to the rebate system used by the Medicaid program.

Additional provisions came into effect at the start of 2024, which include phasing in a cap on out-of-pocket costs for prescription drugs covered under Medicare Part D by eliminating cost sharing above the catastrophic threshold in 2024 and expanding eligibility for full benefits under the Medicare Part D Low-Income Subsidy Program, which assists qualifying beneficiaries with their Part D premiums, deductibles, and cost-sharing expenses.

Starting in 2025, Medicare beneficiaries will pay no more than $2,000 out of pocket for the prescription drugs they take that are covered under Medicare Part D. Other changes to the Medicare Part D program will be introduced in future years.

10. What resources are available to assist Medicare beneficiaries in understanding their coverage options?

People with Medicare can learn more about Medicare coverage options and the features of different plan options by reviewing the Medicare & You handbook. In addition, people can review and compare the Medicare options available in their area by using the Medicare Plan Compare website, a searchable tool on the Medicare.gov website, by calling 1-800-MEDICARE (1-800-633-4227), or by contacting their local State Health Insurance Assistance Program (SHIP). SHIPs offer local, personalized counseling and assistance to people with Medicare and their families. Contact information for state SHIPs can be found by calling 877-839-2675 or by checking the listing provided on the Medicare.gov website.

Additionally, many people use insurance agents and brokers to navigate their coverage options. While helpful, agents and brokers are financially compensated by private insurers for enrolling people in their plans, and often receive higher commissions if people choose a Medicare Advantage plan rather than remaining in traditional Medicare and purchasing a supplemental Medigap policy and stand-alone Part D plan.

Nearly 7 in 10 Medicare Beneficiaries Did Not Compare Plans During Medicare’s Open Enrollment Period

Published: Sep 26, 2024

Issue Brief

Each year, people with Medicare can review their coverage options and change plans during the annual Open Enrollment Period (October 15 to December 7). Medicare beneficiaries with traditional Medicare can compare and switch Medicare Part D stand-alone drug plans or join a Medicare Advantage plan, while enrollees in Medicare Advantage can compare and switch Medicare Advantage plans or elect coverage under traditional Medicare with or without a stand-alone drug plan. Beneficiaries have no shortage of plans to choose from: in 2024, the average Medicare beneficiary can choose among 43 Medicare Advantage plans and 21 Part D stand-alone prescription drug plans (PDPs).

The marketplace of Medicare private plans operates on the premise that people with Medicare will compare plans during the open enrollment period to select the best source of coverage, given their individual needs and circumstances. Coverage and costs vary widely among both Medicare Advantage plans and Part D prescription drug plans and can change from one year to the next, which could lead to unexpected and avoidable costs and disruptions in care for beneficiaries who do not review their options annually. For example, changes in Medicare Advantage provider networks could mean beneficiaries lose access to their preferred doctors, while changes in the list of covered drugs and cost-sharing requirements could result in higher out-of-pocket drug costs. Further, beneficiaries’ health care needs can change from one year to the next. Even without a change made by their plan or a change in health status, beneficiaries may be able to find a plan that better meets their individual needs or lowers their out-of-pocket costs.

In focus groups conducted by KFF, Medicare beneficiaries highlighted many of these factors, including out-of-pocket costs, access to specific doctors, and coverage of prescription drugs, as important in choosing their Medicare coverage. Yet, Medicare beneficiaries also expressed difficulty understanding and comparing the various plan options and being overwhelmed by a barrage of television ads – mostly for Medicare Advantage plans.

In this analysis, KFF examines the share of Medicare beneficiaries who reviewed their coverage and compared plans during the 2021 open enrollment period for coverage in 2022, and who made use of Medicare’s official information resources, as well as variations by demographic groups, based on an analysis of the 2022 Medicare Current Beneficiary Survey (the most recent year available).

Key Takeaways

  • Overall, nearly 7 in 10 (69%) Medicare beneficiaries did not compare their own source of Medicare coverage with other Medicare options offered in their area during the 2021 open enrollment period, while 31% did so. A larger share of beneficiaries in traditional Medicare than in Medicare Advantage did not compare their own source of coverage with other plans (73% vs 65%).
  • Among Medicare Advantage enrollees, more than 4 in 10 (43%) did not review their current plan’s coverage to check for potential changes in their plan’s premiums or other out-of-pocket costs, while the remainder (57%) did so. A similar share (44%) did not review their current plan for potential changes in the kinds of treatments, drugs, and services that would be covered in the following year.
  • Most enrollees in Medicare Advantage prescription drug plans (82%) and stand-alone prescription drug plan (PDPs) (69%) did not compare their plan’s drug coverage with drug coverage offered by other plans in their area.
  • Medicare’s official information resources are used by half or fewer of Medicare beneficiaries, with just a quarter (26%) reporting calling the toll-free number, 4 in 10 (42%) reporting visiting the Medicare website, and slightly more than half (54%) reporting reading some or parts of the Medicare & You handbook

Nearly 7 in 10 Medicare Beneficiaries Did Not Compare Medicare Coverage Options During the Open Enrollment Period for 2022

Overall, most (69%) Medicare beneficiaries reported that they did not compare their current Medicare plan to other Medicare coverage options that were available during the 2021 open enrollment period for coverage in 2022 (Figure 1, Table 1). Among Medicare Advantage enrollees, nearly two-thirds of enrollees (65%) did not compare coverage options for 2022, even though year-to-year changes in Medicare Advantage plans, such as changes in provider networks or prior authorization requirements can affect enrollees’ access to care.

Nearly 7 in 10 Medicare Beneficiaries Did Not Compare Medicare Coverage Options During Open Enrollment Period for Coverage in 2022E

The share of Medicare beneficiaries who did not compare Medicare coverage arrangements was higher among certain subgroups, including beneficiaries with lower incomes and education levels, Hispanic beneficiaries, those dually-enrolled in Medicare and Medicaid, under age 65 with disabilities or ages 85 and older, and beneficiaries with a cognitive impairment (Figure 2, Appendix Table 1).

The Share of Medicare Beneficiaries Who Did Not Compare Medicare Coverage Options During Open Enrollment Was Higher Among Certain Subgroups

More Than 4 in 10 Medicare Advantage Enrollees Did Not Review Their Own Plan for Potential Changes in Covered Costs or Services for the Coming Year

For Medicare Advantage enrollees, premiums, cost sharing, and out-of-pocket limits can vary from year to year and across plans, with Medicare Advantage plans having the flexibility to modify cost sharing for most services, subject to limitations. Medicare Advantage plans may provide extra (“supplemental”) benefits that are not covered in traditional Medicare, but the type and scope of specific services often varies from one year to the next. Additionally, virtually all Medicare Advantage enrollees are in plans that impose prior authorization requirements for certain services, and these plans can alter the list of covered drugs, and broaden or narrow their network of physicians and other providers from one year to the next, subject to federal standards.

More than 4 in 10 (43%) Medicare Advantage enrollees did not review their current plan during the open enrollment period to see whether there would be changes for 2022 to their monthly premiums, deductibles, co-payments, or other out-of-pocket expenses, but the remaining 57% reported doing so (Figure 3, Appendix Table 2). Similarly, 44% of Medicare Advantage enrollees did not review their current plan for changes to the kinds of treatments, drugs, and services offered for their coverage in 2022.

The share of Medicare Advantage enrollees who did not review their own plan for changes in costs or services was higher among certain enrollees, including those with lower incomes and education levels, Black and Hispanic enrollees, individuals self-reporting fair or poor health, enrollees ages 85 and older, and those dually-eligible for Medicare and Medicaid coverage (Figure 3, Appendix Table 2).

For example, half of all Medicare Advantage enrollees reporting fair or poor health did not check to see if there was going to be a change in monthly premiums, deductibles or co-payments in their coverage, or any change in the kinds of treatments, drugs and services that would be covered. Nearly two-thirds of Hispanic (65%) and half of Black (50%) Medicare Advantage enrollees did not review their plan for changes in costs, with a similar pattern for changes in services (64% vs 48%, respectively). Additionally, nearly 60% of adults ages 85 and older did not review their plan for changes in costs (57%) or services (58%).

More Than Four in 10 Medicare Advantage Enrollees Did Not Review Their Current Medicare Plan For Changes in Costs or Services Covered in 2022; the Share Was Higher Among Certain Enrollees

Most Medicare Beneficiaries with Part D Prescription Drug Coverage Did Not Compare Their Plan’s Drug Coverage to Other Drug Coverage Options

Part D plan costs, including premiums, deductibles, and cost-sharing requirements can change from year to year and vary by plan. Additionally, Part D plans can also modify their formularies, including adding or dropping drugs from coverage, and adding or modifying utilization management requirements that apply to specific drugs, such as prior authorization and step therapy.

The prescription drug provisions of the Inflation Reduction Act include changes that will lower out-of-pocket costs for all Part D enrollees, including a new $2,000 cap on out-of-pocket spending starting in 2025. In response to these changes, it is possible that Part D plan sponsors may make changes to plan premiums, formularies and cost sharing, making it particularly important for beneficiaries to compare their prescription drug options during open enrollment.

About 8 in 10 (82%) enrollees in Medicare Advantage plans with prescription drug coverage (MA-PDs) did not compare the drug coverage offered by their own MA-PD to other MA-PDs in their area during the 2021 open enrollment period (Figure 4; Appendix Table 3). Among stand-alone prescription drug plan (PDP) enrollees, a lower share, 69% of enrollees, said they did not compare drug coverage offered by their current PDP to other PDPs.

Most Medicare Beneficiaries Did Not Compare the Drug Coverage Under Their Current Plan to Drug Coverage Offered by Other Medicare Plans

The share of beneficiaries with coverage under MA-PDs or PDPs who did not compare drug coverage offered for coverage in 2022 was higher among women, beneficiaries with lower incomes and education levels, Hispanic beneficiaries, beneficiaries ages 85 and older, and dual-eligible individuals (Appendix Table 3).

Medicare’s Information Resources Are Used by Half or Even Fewer Beneficiaries

Medicare provides information resources to help beneficiaries understand their Medicare benefits, coverage options, and costs, including the 1-800 Medicare toll free number, the Medicare.gov website, and the Medicare & You handbook that is provided each year to all Medicare beneficiaries. But these resources are not widely used, particularly the toll-free number (Figure 5, Appendix Table 4).

Medicare’s Information Resources Are Used by Half or Even Fewer Beneficiaries
  • About a quarter (26%) of Medicare beneficiaries reported calling the 1-800-MEDICARE helpline for information, but the remaining three-quarters (74%) of Medicare beneficiaries reported either never calling the helpline for information (51%) or being unaware that this helpline existed (23%).
  • Four in 10 (42%) Medicare beneficiaries said they (or someone on their behalf) visited the official Medicare website for information, but more than half (58%) said they either never visited the website (36%) or they did not have access to the internet or had no one to access it for them (22%).
  • More than half (54%) of Medicare beneficiaries reported that they had read the Medicare & You handbook (thoroughly or some parts of the handbook), but 46% reported that either they did not read the handbook (31%) or they did not receive it or did not know if they had received it (15%).

The share of Medicare beneficiaries who used Medicare information sources was lower among certain subgroups, including Black beneficiaries, individuals ages 75 to 84, and dual-eligible individuals (Appendix Table 4).

Methods

This analysis uses survey data for community-dwelling Medicare beneficiaries from the Centers for Medicare & Medicaid Services (CMS) Medicare Current Beneficiary Survey (MCBS) 2022 Survey File.

The analysis of 1) the share of beneficiaries who compared Medicare plans during the open enrollment period for 2022 coverage, 2) the share of Medicare Advantage enrollees who reviewed their current coverage for changes in costs or services, and 3) the share of beneficiaries who used Medicare’s official information sources used questions from the Medicare Plan Beneficiary Knowledge topical segment. This analysis was weighted to represent the ever-enrolled Medicare population in 2022 using the topical survey weight KNSEWT and relevant replicate weights. The analysis of the share of beneficiaries who compared Medicare plans and the share of Medicare Advantage enrollees who reviewed their current coverage for changes in costs or services excluded beneficiaries who reported just enrolling in Medicare.

The analysis of MA-PD/PDP drug plan comparison used questions from the Rx Medication topical segment; similar as above, the analysis was weighted to represent the ever-enrolled Medicare population in 2022 using the topical survey weight RXSEWT and relevant replicate weights.

Both analyses excluded beneficiaries with Part A or Part B only, those with Medicare as secondary payer, and those living in long-term care facilities. All reported differences in the text are statistically significant at p<0.05.

 

Appendix

Percent of Medicare Beneficiaries Who Compared Their Current Plans With Other Plans During the Open Enrollment Period For 2022 Coverage, By Demographic Characteristics
Percent of Medicare Advantage Enrollees Who Reviewed Their Current Medicare Plan for Changes in Costs or Services During the Open Enrollment Period for 2022 Coverage
Percent of Medicare Beneficiaries Reporting Prescription Drug Plan Comparison During the Open Enrollment Period for 2022 Coverage
Percent of Medicare Beneficiaries Reporting Use of Medicare Official Resources During the Open Enrollment Period for 2022 Coverage
News Release

Nearly 7 in 10 Medicare Beneficiaries Do Not Compare Coverage Options During Open Enrollment  

Published: Sep 26, 2024

With open enrollment less than a month away, a new KFF analysis suggests that the vast majority of the nation’s 67 million Medicare beneficiaries will not shop around among the coverage options for 2025 or switch plans. It’s a decision that could have a significant impact on enrollees’ coverage and costs.

The analysis of federal data shows that nearly 7 in 10 Medicare beneficiaries (69%) did not  compare their Medicare coverage with other Medicare options during the program’s annual open enrollment period for coverage in 2022. Enrollees in traditional Medicare were slightly more likely to skip shopping around than those in Medicare Advantage plans (73% vs. 65%). 

The Centers for Medicare & Medicaid Services recommends that beneficiaries compare their options because coverage and costs can vary widely, especially among Medicare Advantage plans that now enroll more than half of all eligible Medicare beneficiaries. From one year to the next, Medicare Advantage plans can change their premiums, cost-sharing requirements, provider networks, or prior authorization requirements. For beneficiaries who simply stay put in their existing plan, such changes could lead to unexpected, avoidable costs and disruptions in care.The new analysis examined the subset of Medicare beneficiaries enrolled in a Medicare Advantage plan, finding that 43% of enrollees did not review their own plan’s coverage during the open enrollment period to see whether there would be changes for 2022 to their monthly premiums, deductibles, co-payments, or other out-of-pocket expenses. The share not reviewing their own plan for changes in costs was even higher among enrollees in fair or poor self-assessed health (50%), enrollees who are Black (50%) or Hispanic (65%), and enrollees ages 85 and older (57%).Similarly, 44% of Medicare Advantage enrollees did not review their current plan for changes to the kinds of treatments, drugs, and services offered for 2022.New changes for 2025 include prescription drug provisions in the Inflation Reduction Act of 2022 that will lower out-of-pocket costs for all Part D enrollees, including a new $2,000 cap on out-of-pocket spending starting in January. In response, Part D plan sponsors may make changes to plan premiums, formularies, and cost sharing — making it especially important for beneficiaries to compare their prescription drug options during open enrollment.

In the past, many have not. The analysis shows that 82% of enrollees in Medicare Advantage prescription drug plans and 69% of enrollees in stand-alone Part D prescription drug plan did not compare their plan’s drug coverage with drug coverage offered by other plans in their area for 2022.

More broadly, relatively few beneficiaries use Medicare’s official information resources. The analysis finds that just a quarter (26%) reported calling the toll-free 1-800-Medicare helpline, four in 10 (42%) reported visiting the Medicare website, and slightly more than half (54%) reported reading some or parts of the Medicare & You handbook.

Also released today is KFF’s What to Know about the Medicare Open Enrollment Period and Medicare Coverage Options. It provides information about the kinds of changes Medicare beneficiaries can make to their coverage, how supplemental coverage can factor into decisions, how Medicare supports for low-income people relates to coverage decisions, how the features of traditional Medicare compare to Medicare Advantage, and how prescription drug coverage plans vary.

The Medicare open enrollment period runs from October 15 through December 7.

VOLUME 7

Political Rhetoric Spreads Misinformation About Fentanyl

This is Irving Washington and Hagere Yilma. We direct KFF’s Health Misinformation and Trust Initiative and on behalf of all of our colleagues across KFF who work on misinformation and trust we are pleased to bring you this edition of our bi-weekly Monitor.


Summary

In this edition, we look at how political rhetoric is driving misinformation about fentanyl and immigration. We also highlight the legal implications of fentanyl-laced counterfeit pills sold on social media, address myths about opioid exposure, and discuss how AI may help counter these narratives.


Quote card of white text on a green background reads: "Most adults (80%) have heard the claim that immigrants cause violence. It's the ultimate example of amplification of misinformation by political figures based on the intentional use of anecdotes." from Drew Altman, KFF President and CEO

In his latest Beyond the Data column, KFF CEO Drew Altman examines how media coverage can inadvertently amplify politicians’ misinformation about immigrants. He cites a recent incident in Springfield, Ohio, where false claims about Haitian immigrants, initially made by political candidates, gained traction through media coverage. Altman observes that some politicians are exploiting feelings of alienation among certain Americans by scapegoating immigrants. This misinformation can have serious consequences, especially for Black immigrants who face both racism and anti-immigrant sentiment. He emphasizes that the media must be careful when reporting on such political falsehoods, as repeated coverage showing clips of false statements, even if followed by fact checking, can unintentionally reinforce misinformation.


Recent Developments

Latest KFF Poll Explores Exposure, Belief, and Impact of Misinformation About Immigrants

The latest KFF Health Misinformation Tracking Poll (conducted before the September 10 presidential debate) highlights how misinformation about immigrants is being shared by politicians leading up to the election, with many adults exposed to both false and true claims but remaining unsure of their truthfulness. The September Health Misinformation Tracking Poll found that large majorities of adults have heard elected officials or candidates make the false claims that immigrants are causing an increase in violent crime (80%) or taking jobs and increasing unemployment for U.S.-born adults (74%; Figure 1). While a majority have heard the true statement that immigrants help to fill labor shortages in some industries (69%), far fewer have heard candidates or elected officials make the true claim that immigrants pay billions in taxes annually (31%). 

A Majority of Adults, Including Similar Shares Across Partisans, Say They Have Heard False Claims About Immigrants From Elected Officials or Candidates

Despite this exposure, most people say these statements are either “probably true” or “probably false,” reflecting widespread uncertainty (Figure 2). However, Republicans are far more likely than Democrats or independents to say false claims about immigrants are “definitely true.” Additionally, about half of U.S. adults, including a similar share of immigrants, either incorrectly believe undocumented immigrants are eligible for federally funded health insurance programs or say they are unsure. This misinformation has implications for immigrant health and well-being. The poll also found that nearly four in ten immigrants (36%), including nearly half of Asian immigrants (45%), say former President Trump’s rhetoric has negatively impacted the way they are treated in the U.S. On the other hand, most immigrants (72%) say Vice President Harris’s statements have not affected their treatment, while about one in five say her rhetoric has had a positive effect.

Politicians Incorrectly Link Fentanyl to Migration to Garner Support for Immigration Policy

CorbalanStudio / Getty Images

During this election season, politicians are sharing misinformation about fentanyl and migration to instill fear and promote stricter border policies. Former President Donald Trump and Vice Presidential Candidate JD Vance have repeatedly claimed that undocumented immigrants are responsible for the influx of fentanyl into the U.S., criticizing President Biden and Vice President Harris’ immigration policy and suggesting that building border walls could reduce drug flow. These claims are misleading and not new. An NPR-Ipsos poll from 2022 found that nearly 4 in 10 Americans believe that “most of the fentanyl entering the U.S. is smuggled in by unauthorized migrants crossing the border illegally”. In reality, federal data analyzed by KFF indicates that most fentanyl enters the U.S. through legal ports of entry and is trafficked primarily by U.S. citizens, not migrants.

As fentanyl continues to drive overdose deaths in the U.S., these misleading claims are resonating with some grieving parents who have lost children to fentanyl overdoses and are looking for decisive action against the opioid crisis. A new KFF analysis shows that fentanyl has driven a 23-fold increase in opioid deaths over the past decade, making it the primary cause of overdose fatalities, despite a decline in overall opioid deaths in late 2023. But experts argue that stricter immigration policies will not effectively combat the opioid epidemic. This type of rhetoric misplaces blame, contributing to stigmatization and harmful policies that adversely affect immigrant health. Focusing on this false link neglects the real factors driving fentanyl and opioid overdoses in the U.S., such as misconceptions about treatments for opioids.

Fentanyl-Laced Fake Drugs on Social Media Raises Questions About Accountability

Vladimir Vladimirov / Getty Images

Social media platforms have increasingly contributed to the rise of fentanyl use among youth. Platforms like Instagram, Snapchat, and Telegram have become key venues for drug distribution, allowing young users to order illicit substances, often without knowing they’re laced with fentanyl. Even though social media companies are trying to crack down on drug sales, experts say it’s not enough to keep users safe. Some grieving parents, who’ve lost children to fentanyl-laced pills, are suing companies like Snap for negligence in these tragic fatalities. This legal battle has broader implications for Section 230, which currently provides immunity to online platforms for content posted by users. If these cases succeed, it could lead to stricter rules and more accountability for social media companies.

One way to determine if prescription drugs contain fentanyl is by using fentanyl test strips. Although there is uncertainty about how consistently fentanyl test strips detect fentanyl across brands, lots, and drug combinations, they can still serve as effective harm reduction measures by identifying fentanyl and its analogs in drug samples at low concentrations. Unfortunately, a widespread myth persists that fentanyl contamination is impossible to detect, which keeps many from using these strips. Critics also argue that making fentanyl test strips available might encourage drug use, causing some states to classify them as drug paraphernalia. But harm-reduction evidence shows they prevent overdoses without increasing consumption and a KFF Issue Brief explains that some states are changing their policies to allow access to fentanyl test strips because of the rise of illicit fentanyl in drug supplies. By spreading the myth that fentanyl contamination is undetectable or leads to more drug use, individuals overlook practical solutions that could mitigate the risk and protect vulnerable populations.


Emerging Misinformation Narratives

Myths About Fentanyl Exposure

sturti / Getty Images

A common myth surrounding fentanyl is that simply touching it can be fatal. This fear has been spread by some media reports and misinformed statements. Fentanyl is a powerful opioid, but it isn’t absorbed through the skin or through casual contact.

There have been several high-profile cases where police officers or first responders claimed to have collapsed or overdosed just by touching fentanyl, but medical experts have consistently debunked these reports. In July 2023, multiple local news outlets reported on incidents involving police officers who claimed to have been exposed to fentanyl during their duties. One officer in Indiana stated they had passed out after accidentally inhaling the drug, while another in Colorado reported collapsing after touching it. Similar claims have surfaced in recent years, often sparking discussions on social media. While some users express concern, others question the validity of these reports. For example, in response to the recent incidents, a doctor shared a popular post on X stating, that fentanyl cannot be accidentally inhaled, as it must be snorted or vaporized.

The misconception that simply touching or inhaling fentanyl can lead to overdose can be traced back to an advisory statement issued by the DEA in 2016. Even though experts have repeatedly debunked these myths, public fear of fentanyl remains high. Widespread concerns about the drug are understandable, as fentanyl is involved in more than 70 percent of U.S. overdose deaths, but false narratives about the drug may be drowning out factual information intended to prevent fentanyl-related deaths.


Research Updates

fotosipsak / Getty Images

A study in Journalism Studies that examined media coverage of misinformation during the 2016 and 2020 U.S. presidential elections offers insight into how media outlets addressed election-related false claims. The study identified three core strategies for correcting election-related misinformation: emphasizing correct information without repeating the false claims, adopting a more assertive tone to debunk inaccuracies, and using credible sources to appeal to diverse audiences, including skeptics. As health misinformation continues to underlie political rhetoric leading up to the election, these media approaches could help shape public understanding and counteract harmful narratives.

Source: Juarez Miro, C., & Anderson, J. (2024). Correcting False Information: Journalistic Coverage During the 2016 and 2020 US Elections. Journalism Studies25(2), 218-236.

simplehappyart / Getty Images

Debunking Misinformation May Be More Effective Than Prebunking

A study published in Nature found that debunking misinformation is slightly more effective than prebunking when it comes to correcting false claims. Researchers tested both strategies on over 5,000 participants across multiple European countries, examining how these interventions impacted belief in misinformation. While both methods worked, debunking — delivered after people were exposed to false claims — had a small advantage. However, the study also highlighted the role of trust: debunking was less effective when participants had low trust in the source delivering the correction, emphasizing that trust in institutions remains a factor in countering misinformation effectively.

Source: Bruns, H., Dessart, F. J., Krawczyk, M., Lewandowsky, S., Pantazi, M., Pennycook, G., … & Smillie, L. (2024). Investigating the role of source and source trust in prebunks and debunks of misinformation in online experiments across four EU countries. Scientific Reports, 14(1), 20723.


AI and Emerging Technologies

Personalized AI Debunking: A New Approach to Countering Conspiracy Theories

Teera Konakan / Getty Images

Personalizing debunking efforts can effectively counter conspiracy theories by tailoring arguments to address the specific evidence individuals believe supports their views. A recent study published in Science found that when participants engaged in a personalized, in-depth dialogue with an AI tool designed to refute conspiracy theories, their belief in those conspiracies decreased significantly, with effects lasting for months. This approach challenges the notion that conspiracy beliefs are impervious to change and suggests that AI tools, which can sustain individualized, evidence-based conversations, may be powerful resources for mitigating harmful beliefs.

About The Health Information and Trust Initiative: the Health Information and Trust Initiative is a KFF program aimed at tracking health misinformation in the U.S., analyzing its impact on the American people, and mobilizing media to address the problem. Our goal is to be of service to everyone working on health misinformation, strengthen efforts to counter misinformation, and build trust. 


View all KFF Monitors

The Monitor is a report from KFF’s Health Information and Trust initiative that focuses on recent developments in health information. It’s free and published twice a month.

Sign up to receive KFF Monitor
email updates


Support for the Health Information and Trust initiative is provided by the Robert Wood Johnson Foundation (RWJF). The views expressed do not necessarily reflect the views of RWJF and KFF maintains full editorial control over all of its policy analysis, polling, and journalism activities. The Public Good Projects (PGP) provides media monitoring data KFF uses in producing the Monitor.


Pregnancy-Related Preventive Services for Adults Covered by the ACA

The Affordable Care Act (ACA) requires most private health insurance plans and  Medicaid ACA expansion programs to cover many recommended preventive services without any patient cost-sharing, including pregnancy-related services and supports such as: prenatal visits, folic acid, anxiety and depression screenings, screenings and medication for preeclampsia, STI tests, smoking cessation support, and breastfeeding and lactation counseling and supplies.

The required services are recommended by the U.S. Preventive Services Task Force (USPSTF)and the Health Resources and Services Administration (HRSA) based on recommendations issued by the Women’s Preventive Services Initiative. The Advisory Committee on Immunization Practices recommends vaccines for adults and children that must also be covered without cost-sharing. 

The table below presents detailed information on pregnancy-related preventive services for adults covered under the ACA, including a summary of the recommendation, the target population, effective date of coverage, and related coverage clarifications.

Pregnancy Related

Sexual and Reproductive Health Related Preventive Services for Adults Covered by the ACA

The Affordable Care Act (ACA) requires most private health insurance plans and Medicaid ACA expansion programs to cover preventive services related to sexual and reproductive health with no cost-sharing.  These include—but are not limited to—contraceptive services and supplies for women, as well as counseling and testing for sexually transmitted infections (STIs) and human immunodeficiency virus (HIV), and pre-exposure prophylaxis (PrEP) for HIV prevention.

The required services are recommended by the U.S. Preventive Services Task Force (USPSTF) and the Health Resources and Services Administration (HRSA) based on recommendations issued by the Women’s Preventive Services Initiative. The Advisory Committee on Immunization Practices recommends vaccines for adults and children that must also be covered without cost-sharing. 

The table below presents detailed information on sexual and reproductive health related preventive services that are covered under the ACA, including a summary of the recommendation, the target population, effective date of coverage, and related coverage clarifications. 

Sexual Health

Immunizations for Adults Covered by the ACA

Federal law requires most private health insurance plans and Medicaid programs to cover the full cost of recommended immunizations for adults with no cost-sharing. Vaccine and booster recommendations may vary by age and population. Some of the recommended vaccines that are covered in full, at least for some population groups, are for COVID-19, Human papillomavirus (HPV), measles-mumps-rubella (MMR), and Influenza along with many of the traditional childhood vaccinations.

The Advisory Committee on Immunization Practices (ACIP) develops recommendations for vaccine use to prevent the spread of diseases caused by infections and viruses.

The table below presents detailed information on immunizations for adults covered under the ACA, including a summary of the recommendation, the target population, effective date of coverage, and related coverage clarifications. Ongoing litigation over the scope of the preventive services requirement in the case, Braidwood Management Inc. v. Becerra, could affect coverage policy of preventive health services in the future. 

Immunizations

Health Promotion Preventive Services for Adults Covered by the ACA

The Affordable Care Act (ACA) requires most private health insurance plans and Medicaid ACA expansion programs to cover the full cost of several preventive services related to health promotion, such as counseling on healthy diet, obesity prevention, and alcohol use. Plans must also cover screening for intimate partner violence, urinary incontinence, and checkup visits for women.

The required services are recommended by the U.S. Preventive Services Task Force (USPSTF)and the Health Resources and Services Administration (HRSA) based on recommendations issued by the Women’s Preventive Services Initiative.  The Advisory Committee on Immunization Practices recommends vaccines for adults and children that must also be covered without cost-sharing. 

The table below presents detailed information on clinical preventive services related to health promotion for adults covered under the ACA, including a summary of the recommendation, the target population, effective date of coverage, and related coverage clarifications.

Chronic Conditions

Chronic Condition Preventive Health Services for Adults Covered by the ACA

The Affordable Care Act (ACA) requires most private health insurance plans and Medicaid ACA expansion programs to cover many recommended preventive services without any patient cost-sharing, including services  for prevention and early detection of risks associated with chronic conditions, such as heart disease, diabetes, obesity, hepatitis, anxiety, and depression.

The required services for adults are recommended by the U.S. Preventive Services Task Force (USPSTF)and the Health Resources and Services Administration (HRSA) based on recommendations issued by the Women’s Preventive Services Initiative. The Advisory Committee on Immunization Practices recommends vaccines for adults and children that must also be covered without cost-sharing. 

The table below presents detailed information on preventive health services related to chronic conditions for adults covered under the ACA, including a summary of the recommendation, the target population, effective date of coverage, and related coverage clarifications.  

Chronic Conditions

ACA Preventive Services Tracker

Last Updated on June 27, 2025

The Affordable Care Act (ACA) requires most private health insurance plans and Medicaid ACA expansion programs to cover many recommended health care preventive services for adults without any patient cost-sharing, including preventive services for specific conditions.

Select from the categories below for detailed information on preventive services for each condition covered under the ACA for adults, including a summary of the recommendation, the target population, effective date of coverage, and related coverage clarifications.

The required health services for adults are recommended by the U.S. Preventive Services Task Force (USPSTF) and the Health Resources and Services Administration (HRSA) based on recommendations issued by the Women’s Preventive Services Initiative. The Advisory Committee on Immunization Practices recommends vaccines for adults and children that must also be covered without cost-sharing.